Jennifer S. Graff, PharmD
Articles
September 17th 2015
Developing Evidence That Is Fit for Purpose: A Framework for Payer and Research Dialogue
Rajeev K. Sabharwal, MPH Jennifer S. Graff, PharmD Erin Holve, PhD, MPH, MPP Robert W. Dubois, MD, PhD
A decision-making framework that can be used to harmonize the evidence payer's desire for coverage and formulary decisions with the evidence generated by researchers.
July 21st 2014
Individual Treatment Effects: Implications for Research, Clinical Practice, and Policy
Jennifer S. Graff, PharmD Thaddeus Grasela, PharmD, PhD David O. Meltzer, MD, PhD Robert W. Dubois, MD, PhD
A framework for researchers, providers, payers, or public health bodies identifies when it is most critical to distinguish between "average" population and individual patient response.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: December 12th 2024 | Updated: December 19th 2024
Navigating the Complexities of Neurological Drug Access
